...
首页> 外文期刊>Journal of the International Aids Society >High pre‐exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project
【24h】

High pre‐exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project

机译:与有艾滋病毒感染风险的男男性接触者和变性女性中的高暴露前预防摄入量和早期依从性:PrEP Brasil示范项目

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: The efficacy of pre‐exposure prophylaxis (PrEP) in preventing sexual acquisition of human immunodeficiency virus (HIV) is well established. Little is known about the feasibility of PrEP implementation in middle‐income settings with concentrated epidemics among men who have sex with men (MSM) and transgender women (TGW). Methods: PrEP Brasil is a prospective, multicentre, open‐label demonstration project assessing PrEP delivery in the context of the Brazilian Public Health System. HIV‐uninfected MSM and TGW in 3 referral centres in Rio de Janeiro and S?o Paulo were evaluated for eligibility and offered 48?weeks of daily emtricitabine/tenofovir for PrEP. Concentrations of tenofovir diphosphate in dried blood spot samples (DBS) at week 4 after enrolment (early adherence) were measured. Predictors of drug levels were assessed using ordinal logistic regression models considering the DBS drug level as a 3 level variable ( Results: 1,270 individuals were assessed for participation; n =?738 were potentially eligible and n =?450 were offered PrEP (PrEP uptake was 60.9%). Eligible but not enrolled individuals were younger, had lower HIV risk perception and had lower PrEP awareness. At week 4, 424 participants (of the 450 enrolled) had DBS TFV‐DP concentrations, 94.1% in the protective range (≥350?fmol/punch, consistent with ≥2 pills per week), and 78% were in the highly protective range (≥700 fmol/punch, ≥4 pills per week). Participants with ≥12?years of schooling had 1.9 times the odds (95%CI 1.10–3.29) of a higher versus lower drug level than participants with Conclusions: The high uptake and early adherence indicate that PrEP for high‐risk MSM and TGW can be successfully delivered in the context of the Brazilian Public Health System. Interventions to address disparities on PrEP awareness and HIV risk perception among the younger and less educated are urgently needed in order to maximize the impact of this prevention strategy on the reduction of HIV infection among MSM and TGW in Brazil.
机译:简介:预防接触前预防(PrEP)在预防人类免疫缺陷病毒(HIV)性获得方面的功效已广为人知。关于在中等收入环境中实施PrEP的可行性知之甚少,这种疾病在男男性接触者(MSM)和变性女性(TGW)中集中流行。方法:PrEP Brasil是一个前瞻性,多中心,开放标签的示范项目,在巴西公共卫生系统的背景下评估PrEP的提供。对在里约热内卢和圣保罗的3个转诊中心未感染HIV的MSM和TGW进行了资格评估,并提供48周的每日恩曲他滨/替诺福韦治疗PrEP。在入组后第4周(早期依从性),测量干血斑样品(DBS)中替诺福韦二磷酸的浓度。使用序数Logistic回归模型评估药物水平的预测因素,将DBS药物水平视为3个水平变量(结果:评估了1,270个人的参与度; n =?738有潜在资格,n =?450提供了PrEP(PrEP摄取为合格但未入组的个体较年轻,对艾滋病病毒的风险感知较低,对PrEP的认知较低,在第4周,有424名参与者(450名已纳入研究)的DBS TFV-DP浓度为94.1%(≥保护范围) 350?fmol /打孔,相当于每周≥2片药),其中78%处于高度保护范围内(≥700fmol /打孔,每周≥4片药);受教育年限≥12年的参与者的1.9倍。结论:高摄入量和早期依从性表明,高风险MSM和TGW的PrEP可以在巴西公共卫生系统的背景下成功交付,参与试验的药物水平高于或低于参与者的几率(95%CI 1.10-3.29) 。解决差距的干预措施为了最大程度地提高这一预防策略对减少巴西MSM和TGW中HIV感染的影响,迫切需要在年轻和低学历者中提高PrEP意识和HIV风险感知。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号